share_log

Rapport Therapeutics(RAPP.US) Director Buys US$1.08 Million in Common Stock

Moomoo News ·  Jul 3 20:44

$Rapport Therapeutics (RAPP.US)$ Director HEALY JAMES purchased 44,032 shares of common stock on Jul 1, 2024 at an average price of $24.518 for a total value of $1.08 million.

1720053863952502275.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment